IRIS Accounts Production v24.2.0.383 06456344 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064563442023-03-31064563442024-03-31064563442023-04-012024-03-31064563442022-03-31064563442022-04-012023-03-31064563442023-03-3106456344ns15:EnglandWales2023-04-012024-03-3106456344ns14:PoundSterling2023-04-012024-03-3106456344ns10:Director12023-04-012024-03-3106456344ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106456344ns10:SmallEntities2023-04-012024-03-3106456344ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3106456344ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106456344ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106456344ns10:AbridgedAccounts2023-04-012024-03-3106456344ns10:Director22023-04-012024-03-3106456344ns10:Director32023-04-012024-03-3106456344ns10:CompanySecretary12023-04-012024-03-3106456344ns10:RegisteredOffice2023-04-012024-03-3106456344ns5:CurrentFinancialInstruments2024-03-3106456344ns5:CurrentFinancialInstruments2023-03-3106456344ns5:Non-currentFinancialInstruments2024-03-3106456344ns5:Non-currentFinancialInstruments2023-03-3106456344ns5:ShareCapital2024-03-3106456344ns5:ShareCapital2023-03-3106456344ns5:RetainedEarningsAccumulatedLosses2024-03-3106456344ns5:RetainedEarningsAccumulatedLosses2023-03-3106456344ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-03-3106456344ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-03-3106456344ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3106456344ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106456344ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-3106456344ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-03-3106456344ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3106456344ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-31
REGISTERED NUMBER: 06456344 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

PRIME HEALTHCARE (BURY) LIMITED

PRIME HEALTHCARE (BURY) LIMITED (REGISTERED NUMBER: 06456344)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 7

PRIME HEALTHCARE (BURY) LIMITED

COMPANY INFORMATION
for the year ended 31 March 2024







DIRECTORS: H Newman
Mrs D Teacher
P Newman





SECRETARY: Mrs D Teacher





REGISTERED OFFICE: 88 Crawford Street
London
W1H 2EJ





REGISTERED NUMBER: 06456344 (England and Wales)





ACCOUNTANTS: Cameron Baum Hollander Limited
88 Crawford Street
London
W1H 2EJ

PRIME HEALTHCARE (BURY) LIMITED (REGISTERED NUMBER: 06456344)

ABRIDGED BALANCE SHEET
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,078,286 1,083,967

CURRENT ASSETS
Debtors 55,507 48,518
Cash at bank and in hand 305,080 282,044
360,587 330,562
CREDITORS
Amounts falling due within one year 157,391 185,375
NET CURRENT ASSETS 203,196 145,187
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,281,482

1,229,154

CREDITORS
Amounts falling due after more than one year 5 623,792 679,954
NET ASSETS 657,690 549,200

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 657,590 549,100
SHAREHOLDERS' FUNDS 657,690 549,200

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PRIME HEALTHCARE (BURY) LIMITED (REGISTERED NUMBER: 06456344)

ABRIDGED BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 October 2024 and were signed on its behalf by:





H Newman - Director


PRIME HEALTHCARE (BURY) LIMITED (REGISTERED NUMBER: 06456344)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2024

1. STATUTORY INFORMATION

Prime Healthcare (Bury) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in UK Pound Sterling, which is the functional currency of the company.

Turnover
Turnover is measured at the fair value of the consideration received or receivable from care home residents and other related income, in the normal course of business, net of discounts, rebates, value added taxes and other sales related taxes.

Income is recognised when the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Property, fixtures and fittings, and computer equipment are stated at historical cost less accumulated depreciation and accumulated impairment losses.

Depreciation is recognised to write off the cost of assets less their residual values over their useful lives, using the reducing balance method.

The company's policy is to review the remaining useful economic lives and residual values of fixed assets on an on-going basis and to adjust the depreciation charge to reflect the remaining estimated useful economic life and residual value.

Fully depreciated fixed assets are retained in cost until they are removed from service. In case of disposals, assets and related depreciation are removed from the financial statements and the net amount, less proceeds from disposal, is charged or credited to the profit and loss account.

Assets not carried at fair value are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. An impairment loss is recognised for the amount by which the asset's carrying value exceeds its recoverable amount.

The recoverable amount is the higher of an asset's fair value less costs to sell and value in use. Value in use is defined as the present value of the future pre-tax and interest cash flows obtainable as a result of the asset's continued use. the pre-tax and interest cash flows are discounted using a pre-tax discount rate that represents the current market risk free rate and risks inherent in the asset. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units).

If the recoverable amount of the asset (or asset's cash generating unit) is estimated to be lower than the carrying amount, the carrying amount is reduced to the recoverable amount. An impairment loss is recognised in the profit and loss account, unless the asset has been revalued when the amount is recognised in other comprehensive income to the extent of any previously recognised revaluation. Thereafter any excess is recognised in profit and loss.

If an impairment loss is subsequently reversed, the carrying amount of the asset (or asset's cash generating unit) is increased to the revised estimate of its recoverable amount, but only to the extent that the revised carrying amount does not exceed the carrying amount that would have been determined (net of depreciation) had no impairment loss been recognised in prior periods. A reversal of an impairment loss is recognised in the profit and loss account.


PRIME HEALTHCARE (BURY) LIMITED (REGISTERED NUMBER: 06456344)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Employee benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit and loss in the period to which they relate.

The company provides a range of benefits to employees, including annual bonus arrangements, paid holiday arrangements and defined contribution pension plans.

Short term benefits:
Short term benefits, including holiday pay and other similar non-monetary benefits, are recognised as an expense in the period in which the service is received.

Annual bonus plans:
The company recognises a provision and an expense for bonuses where the company has a legal or constructive obligation as a result of past events and a reliable estimate can be made. This can include discretionary bonuses which have been approved at the year end.

Defined contribution pension plans:
The company operates a defined contribution plan. A defined contribution plan is a pension plan under which the company pays contributions into a separate fund. Under defined contribution plans, the company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

For defined contribution plans, the company pays contributions to privately administered pension plans on a contractual or voluntary basis. The company has no further payment obligations once the contributions have been paid. The contributions are recognised as employee benefit expense when they are due. Prepaid contributions are recognised as an asset to the extent that a cash refund or a reduction in the future payments is available.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 33 (2023 - 27 ) .

PRIME HEALTHCARE (BURY) LIMITED (REGISTERED NUMBER: 06456344)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2023 1,215,426
Additions 3,003
At 31 March 2024 1,218,429
DEPRECIATION
At 1 April 2023 131,459
Charge for year 8,684
At 31 March 2024 140,143
NET BOOK VALUE
At 31 March 2024 1,078,286
At 31 March 2023 1,083,967

5. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE YEARS
2024 2023
£    £   
Repayable otherwise than by instalments
Bank loans more 5 yrs 397,661 452,335

6. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank loans 56,533 56,905

Amounts falling due between one and two years:
Bank loans - 1-2 years 56,533 56,905

Amounts falling due between two and five years:
Bank loans - 2-5 years 169,598 170,714

Amounts falling due in more than five years:
Repayable otherwise than by instalments
Bank loans more 5 yrs 397,661 452,335

The bank loan is secured over the company's freehold property.

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
PRIME HEALTHCARE (BURY) LIMITED

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Abridged Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Prime Healthcare (Bury) Limited for the year ended 31 March 2024 which comprise the Abridged Income Statement, Abridged Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Prime Healthcare (Bury) Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Prime Healthcare (Bury) Limited and state those matters that we have agreed to state to the Board of Directors of Prime Healthcare (Bury) Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Prime Healthcare (Bury) Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Prime Healthcare (Bury) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Prime Healthcare (Bury) Limited. You consider that Prime Healthcare (Bury) Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Prime Healthcare (Bury) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Cameron Baum Hollander Limited
88 Crawford Street
London
W1H 2EJ


23 October 2024